Delivra Health Brands Inc banner

Delivra Health Brands Inc
XTSX:DHB

Watchlist Manager
Delivra Health Brands Inc Logo
Delivra Health Brands Inc
XTSX:DHB
Watchlist
Price: 0.15 CAD 11.11%
Market Cap: CA$4.7m

Wall Street
Price Targets

DHB Price Targets Summary
Delivra Health Brands Inc

Wall Street analysts forecast DHB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DHB is 0.73 CAD with a low forecast of 0.73 CAD and a high forecast of 0.76 CAD.

Lowest
Price Target
0.73 CAD
385% Upside
Average
Price Target
0.73 CAD
390% Upside
Highest
Price Target
0.76 CAD
404% Upside
Delivra Health Brands Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate of Delivra Health Brands Inc's revenue for the next 2 years is 14%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DHB's stock price target?
Price Target
0.73 CAD

According to Wall Street analysts, the average 1-year price target for DHB is 0.73 CAD with a low forecast of 0.73 CAD and a high forecast of 0.76 CAD.

What is Delivra Health Brands Inc's Revenue forecast?
Projected CAGR
14%

The compound annual growth rate of Delivra Health Brands Inc's revenue for the next 2 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett